<code id='AA3115A543'></code><style id='AA3115A543'></style>
      • <acronym id='AA3115A543'></acronym>
      <center id='AA3115A543'><center id='AA3115A543'><tfoot id='AA3115A543'></tfoot></center><abbr id='AA3115A543'><dir id='AA3115A543'><tfoot id='AA3115A543'></tfoot><noframes id='AA3115A543'>
      • <optgroup id='AA3115A543'><strike id='AA3115A543'><sup id='AA3115A543'></sup></strike><code id='AA3115A543'></code></optgroup>
        5. <b id='AA3115A543'><label id='AA3115A543'><select id='AA3115A543'><dt id='AA3115A543'><span id='AA3115A543'></span></dt></select></label></b><u id='AA3115A543'></u>
          <i id='AA3115A543'><strike id='AA3115A543'><tt id='AA3115A543'><pre id='AA3115A543'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / hotspot / knowledge      
           
     
           
      
          knowledge 
           
      
           
      
           
       2025-10-06 11:46:56 
   
      
           
      
           
                        
          knowledge  
          
                                   
                 
                                      author：focus   
                                        
                                      
                                      Page View：48
                                  
                                    
          
                                   
          Editor’s note: A recording of the event is embedded below.
          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.
          advertisement
          Featured Speakers
          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Study: Why relieving medical debt did not improve financial outcomes
                                
                            
          Next article：  
                                      
                                          Trump demands the U.S. pay no more for drugs than other countries … again
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles